EUPRAXIA PHARMACEUTICALS INC.
EPRX
$6.61
▼
-0.15
(-2.22%)
at close
4
Visible periods
5
Metrics
Peer-ranked
Benchmarks
Price Chart
27
Health
Poor
Bearish
auto_awesome
Analytical Summary
EUPRAXIA PHARMACEUTICALS INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.
Market Cap
—
Dividend Yield
—
Revenue Growth
—
Op. Margin
—
ROIC
—
FCF / Share
—
Trailing P/E
—
Price / Book
4.2x
FCF Yield
—
Debt / Equity
—
info
Valuation on last close. End-of-day price, Nov 5, 2026.
trending_up
Bullish Indicators
- No bullish signals detected.
warning
Bearish Risks
- Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile
Health Breakdown
Returns ↑
17
Cash Quality →
50
Financial view
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
Is the balance sheet risky?
1 metrics
⌨️ Keyboard Shortcuts
/ Search
Esc Clear
A Annual
Q Quarterly
1-7 Jump to category
R Reset
Secondary lens
Benchmark Lens
Compare EPRX against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare EPRX against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for EPRX
Bullish
0
No bullish signals detected
Bearish
1
Return on Common Equity (%)
-47.0%
Return on Common Equity (%) is in the bottom quartile
Percentile Rankings
How EPRX compares to all companies
Return on Common Equity (%)
-47.0%
Bottom 25%
Peers: Top 51%
Peer Comparison
EPRX vs similar peers
Return on Common Equity (%)
EPRX
-47.0%
#182 of 357
OTLC
94.9%
RIGL
93.8%
ETST
84.5%
Peer median: -46.81
Profit Margin (%)
EPRX
—
#None of 116
TBPH
98.5%
HCM
83.3%
ZVRA
78.2%
Peer median: -0.34
Debt to Equity
EPRX
—
#None of 93
BIOA
0.00x
ABUS
0.00x
SPRB
0.00x
Peer median: 0.25
Operating Margin (%)
EPRX
—
#None of 112
RPRX
65.6%
PTCT
50.1%
CRMD
48.2%
Peer median: -1.35
Compare EPRX with peers
Stack EPRX against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 5 days ago 4 years · 4 quarters